A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.

Objective: To compare the efficacy of latanoprost, bimatoprost and travoprost for lowering IOP in patients with glaucoma.

Research Design And Methods: In order to carry out this meta-analysis, randomized trials (2001-2004) were identified on Medline and EMBASE using the following key words: glaucoma, ocular hypertension (OHT), randomization, trial, latanoprost, bimatoprost and travoprost. The studies had to compare at least two prostaglandin analogues as mono-therapy.

Epidemiology, impact, management, and cost of Paget's disease of bone in France.

Objectives: To evaluate the epidemiology, quality-of-life (QoL) impact, management, and cost of Paget's disease of bone.

Methods: Retrospective and prospective data were collected in a representative cross-section of office-based and hospital-based rheumatologists in France, in early 2005. Each rheumatologist included consecutive outpatients with Paget's disease seen over a 2-month period.

Nonmedical economic consequences attributable to visual impairment: a nation-wide approach in France.

The nonmedical costs of visual impairment are crucial when allocating resources for prevention or treatment programs. Were analyzed the data from two representative nationwide French surveys aimed at documenting impairments that included 14,603 subjects living in institutions and 16,945 in the community. Three groups were identified: blind (light perception), low vision (loss of shape perception, LV), and controls.

A survey on the prevalence of orofacial herpes in France: the INSTANT Study.

Orofacial herpes is a common benign disease suspected to significantly impact the quality of life (QOL) of affected subjects. The objective of this population-based study was to evaluate the annual prevalence of orofacial herpes in France, its epidemiology, and its impact on QOL. Face-to-face home interviews were conducted among a random sample of 10,263 adults.

Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UK.

Introduction: Visual impairment is a severe disability that puts a heavy burden on individuals, families and society. In developed countries, the two major diseases leading to irreversible visual impairment are glaucoma and age-related macular degeneration. Their prevalence will increase dramatically with population aging.